EDP-514

N/A

Report date: 2025/03/19 14:54:46
NME

Base Information

Drug NameEDP-514
Drug Alias NameEDP-514
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis B virus capsid protein inhibitors
TargetsHepatitis B virus capsid protein
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesTaiwan +[5] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEnanta Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnanta Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsHepatitis B, ChronicHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A